In response to the COVID-19 pandemic, Gladstone scientists have rapidly pivoted the focus of their research labs to the novel virus, SARS-CoV-2. Specifically, they are leveraging their established tools, unique infrastructure, and diverse expertise in virology to develop improved diagnostics, identify targeted treatment strategies, and invent preventative approaches. Gladstone scientists were instrumental in converting HIV/AIDS from a uniformly lethal disease into a chronic condition, and are now bringing the same urgency and focus to combatting COVID-19 in a comprehensive manner. A few examples are detailed below.
This work is made possible in part because Gladstone has biosafety level 3 (BSL-3) facilities on-site, which are now dedicated to work on COVID-19. The BSL-3 research will be overseen by Melanie Ott, in partnership with UC San Francisco and its Institutional Biosafety Committee and Director of High Containment Laboratories.
In the coming weeks Gladstone will open a Biosafety Level 3 (BSL-3) lab which will allow researchers to carry out research with live viruses while keeping themselves, the building, and the environment safe from contamination. Melanie Ott, MD, PhD, and BSL-3 Lab Director Mauricio Montano answer some of the questions around this decision and its potential impact.
To ensure our work does the greatest good, Gladstone Institutes focuses on conditions with profound medical, economic, and social impact—unsolved diseases. Gladstone is an independent, nonprofit life science research organization that uses visionary science and technology to overcome disease. It has an academic affiliation with UC San Francisco.
Direct line: 415.734.5000
Gladstone Institutes is an independent, nonprofit life science research organization that uses visionary science and technology to overcome disease. Established in 1979, it is located in the epicenter of biomedical and technological innovation, in the Mission Bay neighborhood of San Francisco. Gladstone has created a research model that disrupts how science is done, funds big ideas, and attracts the brightest minds.
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Gladstone scientists make headway toward new treatments for people with chronic long-term effectsGladstone Experts Traumatic Brain Injury Neurological Disease Akassoglou Lab Paz Lab Srivastava Lab
Improvements in the cell analysis technique known as flow cytometry are helping Gladstone researchers make discoveries in immunology, stem cell biology, cardiology, and neuroscienceGladstone Experts Flow Cytometry Core Neurological Disease Alexanian Lab Roan Lab
Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winterGladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab